Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Fda Inspections
  6. /
  7. Gland Pharma Limited, Units I+II Pashamylaram Site
FDA Inspection
•Gland Pharma Limited, Units I+II Pashamylaram Site•August 26, 2023

Gland Pharma Limited, Units I+II Pashamylaram Site – FDA Inspection, Aug 26, 2023

Record Details

This FDA Inspection record concerns Gland Pharma Limited, Units I+II Pashamylaram Site, with an inspection on August 26, 2023, issued by the Center for Devices and Radiological Health, covering devices.

Company
Gland Pharma Limited, Units I+II Pashamylaram Site
Inspection Date
August 26, 2023
Product Type
Devices
Office
Center for Devices and Radiological Health
Person
  • Dipesh K. Shah
View Company Profile

ID · 955ba795-ebdd-4ebb-861f-16909163e529

Inspection Facts

Voluntary Action Indicated (VAI)

Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.

Inspection number
1216053
FDA center
Medical Devices & Rad Health
Project area
Compliance: Devices
Outcome
Form 483 issued

FDA Citations

4
  1. 21 CFR 820.70(g)Equipment Installation, Placement, Specified Requirements
  2. 21 CFR 820.186QSR
  3. 21 CFR 820.186QSR
  4. 21 CFR 820.70(g)Equipment Installation, Placement, Specified Requirements

Full citation text and observation details available on the Dashboard.

Other FDA inspections of Gland Pharma Limited, Units I+II Pashamylaram Site

6
DateClassificationOfficeProject area
August 2, 2024Not classifiedOffice of Inspections and InvestigationsDrug Quality Assurance
June 27, 2023VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
November 7, 2019VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
May 29, 2018Not classifiedOffice of Inspections and Investigations
February 23, 2018VAICenter for Drug Evaluation and ResearchDrug Quality Assurance
View all 6 other inspections on the company page
Other documents for Gland Pharma Limited, Units I+II Pashamylaram Site
  • FDA Inspection 1244660 - 2024-08-02
  • FDA Inspection 1210478 - 2023-06-27
  • FDA Inspection 1109239 - 2019-11-07
  • FDA Inspection 1057719 - 2018-05-29
  • FDA Inspection 1043371 - 2018-02-23

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Gland Pharma Limited, Units I+II Pashamylaram Site
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.